Symrise has taken the wraps off SymLash Xtreme, an ingredient scientifically proven to significantly enhance eyelash density with visible results in two weeks.
SymLash XTreme combines a lipopeptide with the well-known blood microcirculation agent troxerutin.
The patented formula provides additional follicle protection and its ready-to-use liquid format makes it easy to formulate into a variety of eye cosmetics.
Inspired by the market trend favouring multi-target approaches to eye beauty care, Symrise is adding this novel solution to its specialized portfolio of cosmetic ingredients for eyelash and brow care.
SymLash XTreme improves eyelash density with noticeable results in two weeks and up to 35% density increase after six weeks.
Keratinocyte stimulation and follicle protection elevate the overall appearance of eyelashes and lead to these results.
Thanks to its liquid format with good water solubility, it is easy to handle and formulate. It is suitable for use in a variety of cosmetics, including eyeliners, eyelash serums, eyebrow mascaras and liners.
“With SymLash XTreme, we’re taking a comprehensive approach to eyelash care – enabling our customers to offer enhanced eyelash density and follicle protection, both efficiently and cost-effectively,” said Marcia Paula, Global Category Director Hair Care at Symrise.
“With our strong track record in lipopeptides, SymLash XTreme aims at helping our customers to meet the growing consumer demand for natural eyelash fullness more easily than ever.”
